US Patent

US12053546 — Stabilized topical formulations containing core-shell microcapsules

Formulation · Assigned to Sol Gel Technologies Ltd · Expires 2032-06-29 · 6y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects stabilized topical formulations containing core-shell microcapsules for topical application.

USPTO Abstract

The present disclosure relates to compositions for topical application, where the compositions comprise microcapsules having a core that comprises benzoyl peroxide and a shell that comprises an inorganic polymer, microcapsules having a core that comprises a retinoid and a shell that comprises an inorganic polymer, and a stabilizing agent. The composition can be in a variety of forms, such as emulsion and gel.

Drugs covered by this patent

Patent Metadata

Patent number
US12053546
Jurisdiction
US
Classification
Formulation
Expires
2032-06-29
Drug substance claim
No
Drug product claim
Yes
Assignee
Sol Gel Technologies Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.